Krilogy Financial LLC Takes $677,000 Position in Globe Life Inc. $GL

Krilogy Financial LLC bought a new stake in shares of Globe Life Inc. (NYSE:GL) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,061 shares of the company’s stock, valued at approximately $677,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Norges Bank bought a new position in Globe Life during the second quarter valued at $157,722,000. AQR Capital Management LLC boosted its stake in shares of Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after purchasing an additional 696,548 shares during the period. Invesco Ltd. grew its holdings in Globe Life by 3.9% during the 2nd quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock valued at $487,396,000 after purchasing an additional 147,644 shares during the last quarter. Candriam S.C.A. purchased a new stake in Globe Life in the 2nd quarter worth about $17,997,000. Finally, Natixis raised its position in Globe Life by 348.3% in the 2nd quarter. Natixis now owns 158,823 shares of the company’s stock worth $19,740,000 after purchasing an additional 123,396 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Price Performance

Shares of GL opened at $144.46 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. The company’s fifty day moving average price is $140.57 and its 200-day moving average price is $138.44. Globe Life Inc. has a 1-year low of $109.38 and a 1-year high of $152.71. The firm has a market capitalization of $11.50 billion, a PE ratio of 10.26 and a beta of 0.47.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The business’s revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities research analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on GL shares. Wells Fargo & Company cut their target price on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Evercore cut Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price objective on the stock. in a research note on Tuesday, January 6th. Piper Sandler restated an “overweight” rating and issued a $167.00 price target on shares of Globe Life in a report on Friday, November 21st. JPMorgan Chase & Co. boosted their price target on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings cut shares of Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, January 14th. Seven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Globe Life presently has a consensus rating of “Moderate Buy” and an average price target of $171.00.

Insider Transactions at Globe Life

In other news, CEO Frank M. Svoboda sold 9,379 shares of the stock in a transaction on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the sale, the chief executive officer owned 35,868 shares in the company, valued at $5,036,943.24. This represents a 20.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Clay Majors sold 30,000 shares of the firm’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $146.89, for a total transaction of $4,406,700.00. Following the transaction, the executive vice president directly owned 47,066 shares of the company’s stock, valued at approximately $6,913,524.74. This trade represents a 38.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 51,129 shares of company stock worth $7,414,035 in the last ninety days. Corporate insiders own 1.51% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.